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Abstract: Herein, we broaden the application scope of 
(cyclopentadienone)iron complexes 1 in C=N bond reduction. 
The catalytic scope of pre-catalyst 1b, which is more active than 
the ‘Knölker complex’ (1a) and other members of its family, has 
been expanded to the catalytic transfer hydrogenation (CTH) of 
a wider range of aldimines and ketimines, either pre-isolated or 
generated in situ. The kinetics of 1b-promoted CTH of ketimine 
S1 were assessed, showing a pseudo-first order profile, with 
TOF = 6.07 h-1 at 50% conversion. Moreover, the chiral complex 
1c and its analog 1d were employed in the enantioselective 
reduction of ketimines and reductive amination of ketones, 
giving fair to good yields and moderate enantioselectivity. 
Introduction 
In recent years, the catalytic applications of 
(cyclopentadienone)iron complexes[ 1 ] (1 in Scheme 1) have 
been increasingly studied. This growing interest is due to several 
attractive features which distinguish this class of complexes from 
most other Fe-based homogeneous catalysts:[ 2 ] i) they are 
relatively easy to prepare and do not contain air-sensitive 
phosphine ligands; ii) they are stable to air, moisture and column 
chromatography; iii) they can be activated in situ by either de-
coordination of a CO ligand[3,4,5,6,7,8a-e,g] (Activation mode I in 
Scheme 1) or conversion into the corresponding 
(hydroxycyclopentadienyl)iron complexes 2 (Activation mode II 
in Scheme 1).[8f,9] 
Although it has been recently reported that 
(cyclopentadienone)iron complexes can also promote C-N and 
C-O bond-forming reactions,[7] most catalytic applications rely on 
their ability to reversibly transfer H2 to polar double bonds, 
following different pathways (Scheme 1). According to Path I, 
the activated catalysts act-1 can dehydrogenate alcohols and 
form the (hydroxycyclopentadienyl)iron complexes 2, which then 
transfer H2 to a polar double bond (transfer hydrogenation). In 
the presence of an excess of alcohol (typically iPrOH) or other 
reducing agent (e.g. formic acid), this path leads to the reduction 
of substrate’s C=O or C=N bond,[3,4a,9b] whereas Oppenauer-type 
alcohol oxidation can be achieved in the presence of excess 
ketone (e.g., acetone).[3b,e,10] 
Scheme 1. Catalytic use of complexes 1 in reactions involving hydride transfer. 
 
Moreover, redox-neutral reactions are also possible (Scheme 1, 
path in green), in which an alcohol substrate – in the presence of 
an amine – is oxidized and converted into an imine/iminium ion 
that is then reduced without net hydrogen consumption 
(‘hydrogen borrowing’ alcohol amination).[5,6,9a,c] Alternatively, 
according to Path II (Scheme 1) complex act-1 can directly split 
molecular hydrogen and form catalyst 2, which then reduces the 
substrate (hydrogenation[4b-e,8,9d-g]). In both Path I and II, 
hydrogen transfer occurs through a pericyclic transition state 
involving both the iron atom and the ‘non-innocent’ ligand 
swinging between the cyclopentadienone (act-1) and the 
hydroxycyclopentadienyl form (2).[9h,i,11] 
Among the redox transformations promoted by complexes act-1 
and 2, C=N reduction[ 12 ] is one of the most important and 
probably the one with the largest potential for improvement. 
Renaud and co-workers pioneered the reductive amination of 
carbonyl compounds promoted by in situ activated 
(cyclopentadienone)iron complexes under hydrogenation 
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conditions.[8c,d,g] However, this methodology suffers from several 
limitations such as sub-optimal yields, high catalyst loading and 
relatively narrow substrate scope, covering mostly aldehydes 
and only a few ketones. 
 
Figure 1. A: Scope limitations of the classical ‘Knölker complexes’ (1a and 2a) 
in C=N reduction. B: Studies on pre-catalyst 1b described previously.
[4a]
 C: 
Studies on C=N reduction, including the use of chiral complexes 1c-d, 
reported in this work. CTH = catalytic transfer hydrogenation; CH = catalytic 
hydrogenation; ATH = asymmetric transfer hydrogenation; AH = asymmetric 
hydrogenation. 
 
In general, the act-1- or 2-promoted reduction of ketimines 
(either generated in situ from ketones, or pre-isolated) proved a 
challenging task, which was achieved by Zhao (in transfer 
hydrogenation)[9b] and Beller (in highly efficient and 
enantioselective hydrogenation)[9d-g] employing, respectively, a 
Lewis acid and a chiral Brønsted acid co-catalyst. Besides 
intrinsically poor atom economy (two catalysts for a single 
transformation), the latter approach has the limitation of 
employing mostly the isolated complexes 2, which are sensitive 
to air and light. Last but not least, no chiral type-1 or type-2 
complex has been yet developed to achieve the enantioselective 
hydrogenation of ketimines in the absence of chiral co-catalysts. 
In a recent communication,[4a] we reported our efforts to develop 
more efficient C=N bond reduction protocols building on the 
(cyclopentadienone)iron complex 1b (Figure 1 B), previously 
synthesized in our labs[4b] and found to be a remarkably more 
active reduction pre-catalyst than the classical ‘Knölker 
complexes’ 1a and 2a. Unlike the latter (Figure 1 A),[9g] catalyst 
1b is able, upon activation with Me3NO, to promote the catalytic 
transfer hydrogenation (CTH) of acetophenone-derived 
ketimines (Figure 1 B) and other ketimines/aldimines in good 
yields using relatively low loading (0.5-2 mol%). Exploiting the 
high activity of pre-catalyst 1b, a CTH-based protocol for the 
reductive amination of aldehydes and ketones was also 
developed.[4a] 
 
The present paper accounts for our efforts to further implement 
the potential of (cyclopentadienone)iron complexes in C=N 
reduction using pre-catalyst 1b, the chiral complex 1c[4d,e] and its 
modified analog 1d (Figure 1 C). 
Results and Discussion 
First, pre-catalyst 1b was tested in the presence of reducing 
agents different from iPrOH. The screening was carried out 
using the N-arylimine S1, which Beller[9g] and Zhao[9b] reported 
as poorly reactive in catalytic hydrogenation (CH) and in CTH 
promoted by catalyst 2a in the absence of co-catalysts. 
Table 1. Reduction of (E)-N-(4-methoxyphenyl)-1-phenylethan-1-imine S1 
promoted by pre-catalyst 1b.
[a]
  
 
# Hydrogen donor 
Cat. loading 
[mol%] 
Solvent 
Conv. 
[%]
[b]
 
1 iPrOH 5 iPrOH 72 
2 5:2 FA/TEA
[c]
 5 - 38 
3 H2
[d]
 5 Toluene 22 
4 H2
[d]
 5 CH3OH 60 
5 H2
[d]
 10 Toluene 98 
6 H2
[d]
 10 CH3OH >99 
[a] Reaction conditions: T = 70 °C, 18 h. C0,sub. = 0.4 M; [b]
 
Determined by 
1
H 
NMR of the crude reaction mixture; [c] FA = formic acid; TEA = 
trimethylamine; [d] PH2 = 20 bar. 
 
As shown in Table 1, imine S1 was subjected to different 
reduction conditions in the presence of in situ activated complex 
act-1b. Catalyst activation, which was found critical in order to 
obtain reproducible results, was performed by adding 
Me3NO
[8d,10] to a rather concentrated solution of 1b (Cprecat. ≥ 0.1 
M) and then stirring for 20 min at r.t. before adding the substrate. 
Replacing iPrOH, used in our previously reported CTH 
methodology,[4a] with the FA/TEA azeotropic mixture (FA = 
formic acid; TEA = triethylamine) led to a drop of conversion, 
possibly because of rapid degradation of the active catalyst 
occurring in the acidic reaction environment (Table 1, entry 2 vs. 
1). Also switching from CTH (with iPrOH) to CH conditions led to 
lower conversions (Table 1, entries 3-4 vs. 1), which could be 
improved only by increasing the catalyst loading to 10 mol% 
(entries 5-6). These results led us to opt for CTH with iPrOH as 
the optimal reduction method for expanding the application 
scope of pre-catalyst 1b. 
We thus tested pre-catalyst 1b with a number of aldimine 
substrates under the previously established optimal conditions[4a] 
(iPrOH, 100 °C, C0,sub. = 0.25 M, 1 mol% catalyst loading), 
obtaining the results shown in Table 2. All reactions were carried 
out on 0.5 mmol scale, and the yield of isolated product was 
calculated in each case. All the N-p-methoxyphenyl (PMP) 
    
 
 
 
 
 
aldimines (Table 2, entries 1, 3-5) were reduced in nearly 
quantitative yield with the exception of the 4-nitroaniline-derived 
imine S3 (entry 2). Remarkably, imine reduction occurred 
chemoselectively and the reducible groups of substrates S3 and 
S4 (-NO2 and -CN, respectively) remained unaffected under the 
experimental conditions. Notably, also the heterocyclic 
substrates S5 and S6 (Table 2, entries 4-5) reacted smoothly, 
despite the presence of a heteroatom which could potentially 
poison the Fe center. We next varied the imine N-substituent, to 
ascertain its effect on reactivity: as expected, the N-phenyl-
protected substrates S7 and S8 reacted in high yields (Table 2, 
entries 6-7). The N-benzylimines S9, S10 and S11 showed 
lower reactivity compared to their N-aryl counterparts S5 and S6 
(Table 2, entries 8-10 vs. 4-5).[13] Substrate S12, possessing the 
easily removable benzhydryl protecting group at nitrogen, gave 
similar yield to the N-benzyl substituted analog S9 (Table 2, 
entry 11 vs. 8). Three ketimine substrates were also tested 
(Table 2, entries 12-14), as a complement to the screening 
previously reported by our group.[4a] In these reactions, 2 mol% 
catalyst loading was used due to the lower reactivity of ketimines 
compared to aldimines. The acetophenone-derived substrate 
S13, bearing a bromine substituent that allows further 
functionalization by cross-coupling chemistry, was converted in 
good yield and without trace of de-bromination byproduct (Table 
2, entry 12). Ketimines S14 and S15, deriving from aliphatic 
ketones, were also included in the screening and underwent 
CTH in quantitative yield (Table 2, entries 13-14), thus 
demonstrating that the application scope of 1b is not restricted 
to aryl ketones. 
Table 2. Extension of scope evaluation in imine CTH promoted by pre-catalyst 
1b.
[a] 
 
# Substrate 
Yield 
[%]
[b]
 
# Substrate 
Yield 
[%]
[b]
 
1 
 
99 8 
 
66 
2 
 
46 9 
 
36
[c]
 
3 
 
99 10 
 
66 
4 
 
99 11 
 
67 
5  99 12 
 
68
[d]
 
6 
 
99 13 
 
99
[d]
 
7 
 
99 14 
 
99
[d]
 
[a] Reaction conditions: substrate/1b/Me3NO = 100:1:2, C0,sub.= 0.25 M (0.5 
mmol), T = 100 °C, 18 h, solvent: iPrOH. PMP = p-methoxyphenyl; [b] Isolated 
yields; [c] NMR yield; [d] Substrate/1b/Me3NO = 100:2:4. 
 
To get additional information on the catalytic properties of 
complex 1b in C=N reduction, we set to study the kinetics of 
ketimine S1 CTH (see Scheme Table 1) promoted by this pre-
catalyst. 
 
Figure 2. Kinetics of the CTH of S1 promoted by complex 1b: • Conversion to of P1 (GC); • Percent of unreacted S1. Conditions: S1/1b/Me3NO =100:5:10; 
solvent: iPrOH; C0,S1 = 0.25 M (0.5 mmol); T = 100 °C; Ccat. = 12.5 mM. 
    
 
 
 
 
 
The reaction was run in iPrOH at 100 °C in the presence of 5 
mol% 1b and 10 mol% Me3NO, and conversion was determined 
by GC analysis of samples taken at regular intervals (every 15 
min in the first 3 h and later every 30 min). As can be seen in 
Figure 2, the reaction showed pseudo-first order dependence on 
substrate concentration, S1 having a half-life of 98.9 min under 
the experimental conditions, corresponding to an average TOF 
of 6.07 h-1 at 50% conversion. A comparison with the classical 
Knölker complex 1a is not possible, since very low conversions 
(2%) were obtained with this complex in the same reaction.[4a] 
Following the successful use of 1b-promoted CTH in the 
reductive amination of aldehydes and ketones,[4a] in this work we 
devoted additional efforts to study the scope of this attractive 
methodology. As already reported, effective and reproducible 
imine formation was found crucial for success of reductive 
amination, the best conditions[4a] being exemplified in Scheme 2. 
Scheme 2. Examples of optimized conditions
[4a]
 for the in situ formation of 
aldimines (A) and ketimines (B). TFA = trifluoroacetic acid. 
 
Table 3. CTH-based reductive amination of aldehydes promoted by pre-
catalyst 1b.
[a,b]
 
 
# Product 
Yield 
[%]
[c]
 
# Product 
Yield 
[%]
[c]
 
1 
 
99 4 
 
17
[d] 
2 
 
44 5 
 
38 
3 
 
98 6 
 
67 
[a] Reaction conditions: aldehyde/amine/1b/Me3NO = 100:150:5:5. Imine 
formation: toluene, 100 °C, 3 Å MS (400 mg), 1 h. Catalyst activation: iPrOH, 
Me3NO, r.t., 20 min. CTH: 3:1 iPrOH/toluene, C0,sub. in CTH = 0.25 M (0.5 
mmol), 100 °C, 18 h; [b] The aldehydes used were distilled over PPh3 prior to 
use; [c] Isolated yields; [d] Yield determined by 
1
H NMR. 
 
We thus screened a number of new aldehyde (Table 3) and 
ketone substrates (Table 4) following the optimized reductive 
amination protocol:[4a] pre-catalyst 1b was activated with Me3NO 
in iPrOH, and then added to the imine generated in situ in 
toluene, so that reduction was carried out in a 3:1 iPrOH/toluene 
mixture. Compared to the CTH of isolated imines, the catalyst 
loading was slightly increased (to 5 mol%) due to the more 
challenging nature of reductive amination. The aldehyde 
substrates were screened in combination with p-anisidine and 
phenethylamine, giving the results shown in Table 3. Both an 
aromatic and a heteroaromatic substrate (Table 3, entries 1 and 
3, respectively) were converted into the corresponding N-PMP 
amines in excellent yields, whereas the sterically hindered 
salicylaldehyde formed product P18 in only 44% yield (entry 2). 
Isobutyraldehyde showed poor reactivity (Table 3, entry 4), 
whereas the in situ formed N-alkyl imines proved reactive and 
formed the corresponding products P20 and P21 in fair to good 
yield (entries 5-6). 
Next, the more challenging ketone reductive amination was 
performed by screening a series of ketones in the presence of  
p-anisidine. In these experiments, N,N-diisopropylethylamine 
(DIPEA - 15 mol%) was added to the mixture before the 
activated catalyst, in order to quench the catalytic amount (10 
mol%) of trifluoroacetic acid (TFA) previously added to 
accelerate imine formation, which would otherwise degrade the 
catalyst act-1b.[4a] Delightfully, both aromatic (Table 4, entries 1, 
3 and 5) and aliphatic ketones (entries 2, 4) were converted into 
the corresponding N-PMP-amines in moderate to good yields 
(ranging from 31% to 68%), including the challenging cyclic 
substrates (entries 2 and 5). 
Table 4. CTH-based reductive amination of ketones promoted by pre-catalyst 
1b.
[a,b]
 
 
# Product 
Yield 
[%]
[c]
 
# Product 
Yield 
[%]
[c]
 
1 
 
31 4 
 
52 
2 
 
41 5 
 
51 
3 
 
68    
[a] Reaction conditions: ketone/amine/1b/Me3NO = 100:150:5:5. Imine 
formation: toluene, 100 °C, 3 Å MS (400 mg), TFA (10 mol%), 2 h. Catalyst 
activation: iPrOH, Me3NO, r.t., 20 min. CTH: 3:1 iPrOH / toluene, C0,sub. in CTH 
= 0.25 M (0.5 mmol), DIPEA (15 mol%), 100 °C, 18 h; [b] Toluene and DIPEA 
were freshly distilled over sodium/benzophenone and CaH2, respectively; [c] 
Isolated yields. 
 
In 2015, our research group reported a new class of BINOL-
derived chiral (cyclopentadienone)iron complexes, and their use 
in the asymmetric hydrogenation (AH) of ketones.[4d,e] These 
pre-catalysts proved slightly less active than the ‘Knölker 
complex’ 1a (Figure 1 A) and showed a moderate 
enantioselectivity (up to 77% ee with the best complex 1c, 
shown in Figure 1 C).[1a] Building on the experience gained in the 
transfer hydrogenation of imines with complex 1b, we decided to 
test our chiral complexes also in the asymmetric transfer 
hydrogenation (ATH) of ketimines. Although – as mentioned 
above – most (cyclopentadienone)iron complexes are not 
sufficiently active to promote the reduction of ketimines,[9f]  Zhao 
    
 
 
 
 
 
and co-workers recently reported that the latter substrates can 
be activated in the presence of a Lewis acid co-catalyst.[9b] 
However, a preliminary test of pre-catalyst 1c in the presence of 
Me3NO and Fe(acac)3 in the CTH of ketimine S1 gave no 
conversion (Table 5, entry 1). 
In the attempt to increase the reactivity of the cyclopentadienone 
iron complex, pre-catalyst 1d was prepared by dissociation of 
one CO ligand by Me3NO and replacement with benzonitrile 
(Scheme 3). In this case the activated form act-1d can be 
obtained by thermal dissociation of the labile nitrile ligand.[14] 
 
Scheme 3. Synthesis of the nitrile-substituted chiral complex 1d. 
 
We tested the catalytic activity of complex 1d in the CTH of N-(4-
methoxyphenyl)-1-phenylethan-1-imine S1 in the presence of 
several Lewis acids (see Supporting Information and Table 5). 
Table 5. Optimization of the imine S1 ATH promoted by chiral pre-catalysts 
1c-d.
[a] 
 
# Pre-cat. Lewis acid 
Amount of Lewis acid  
[mol%] 
Conv. [%]
[b]
 
1 1c
[c] 
Fe(acac)3 40 0 
2 1d - - 0 
3 1d Fe(acac)3 10 12 
4 1d Fe(acac)3 20 44 
5 1d Fe(acac)3 40 36 
6 1d AgF 40 25 
[a] Reaction conditions: S1/Pre-cat. = 100:5, solvent: iPrOH, T = 110 °C, 48 h, 
C0,S1 = 0.5 M (1 mmol); [b] Determined by 
1
H NMR; [c] Complex 1c pre-
activated in the presence of 10 mol% Me3NO for 20 min at r.t.. 
 
As expected, no conversion was obtained without Lewis acid 
(Table 5, entry 2). On the contrary, appreciable conversions 
were achieved in the presence of Fe(acac)3 (Table 5, entries 3-
5) and AgF (entry 6), 20 mol% of the former giving the best 
result (entry 4). Under the optimized conditions, three ketimines 
were screened, giving the results shown in Table 6: substrates 
S1 and S22 were reduced with moderate conversion and poor 
enantioselectivity (entries 1 and 2), whereas imine S26 did not 
react at all (entry 3). The 1d/Fe(acac)3 catalytic system was also 
tested under hydrogenation conditions, in order to possibly 
achieve better conversion than in the ATH protocol. As shown in 
Table 7, good conversions were indeed obtained for all the three 
substrates, but unfortunately the level of enantioselectivity 
remained similar to the one observed in ATH. 
Table 6. Ketimine ATH promoted by pre-catalyst 1d.
[a] 
 
# Substrate Conv. [%]
[b]
 ee [%] 
1 
 
44 33, R
[c]
 
2 
 
38 24, R
[d]
 
3 
 
0 - 
[a] Reaction conditions: imine/1d/Fe(acac)3 = 100:5:20; solvent: iPrOH, C0,sub. 
= 0.5 M (1 mmol), T = 110 °C, 48 h; [b] Determined by 
1
H NMR; [c] Determined 
by chiral HPLC. Absolute configuration assigned by comparing the order of 
elution with literature data (see the Supporting Information); [d] Determined by 
chiral HPLC. Absolute configuration assigned by comparison of the optical 
rotation sign (see the Supporting Information). 
 
Table 7. Ketimine AH promoted by pre-catalyst 1d.
[a] 
 
# Substrate Conv. [%]
[b]
 ee [%] 
1 
 
81 33, R
[c]
 
2 
 
99 7, R
[c]
 
3 
 
74 31, (+)
[e] 
[a] Reaction conditions: imine/1d/Fe(acac)3 = 100:5:20; H2 (50 bar); solvent: 
MeOH, C0,sub. = 0.5 M (0.5 mmol), T = 85 °C, 18 h; [b] Determined by 
1
H NMR; 
[c] See footnotes [c] and [d] of Table 6; [e] Determined by chiral HPLC: no 
correlation between sign of optical rotation and absolute configuration has 
been established so far. 
 
Finally, we tried to establish an enantioselective reductive 
amination protocol based on complex 1d. As this pre-catalyst 
showed higher activity in CH than in CTH (see Table 7 vs. Table 
6), we decided to use hydrogenation for the reduction step. Thus, 
after imine formation (run in MeOH at reflux for 1 h), pre-catalyst 
1d (5 mol% loading) was added and then the mixture was 
reacted overnight at 85 °C under 50 bar of H2. As shown in 
Table 8, the reductive amination of acetophenone and 4-
chloroacetophenone proceeded, respectively, in good and fair 
yield and with a level of enantioselectivity quite modest but 
slightly higher than the one observed for isolated ketimines S1 
and S26 (see Table 6 and 7). 
 
 
 
 
    
 
 
 
 
 
Table 8. CH-based reductive amination of ketones promoted by pre-catalyst 
1d.
[a]
 
 
# Product Yield [%]
[b]
 ee [%]
[c] 
1 
 
68 42 
2 
 
33 47
 
[a] Reaction conditions: ketone/amine/1d = 100:120:5. Imine formation: MeOH, 
reflux, 1 h. CH: MeOH, C0,sub. in CTH = 0.5 M (0.2 mmol), 85 °C, 18 h; [b] 
Isolated yields; [c] Determined by chiral HPLC on the amine derivatives (Boc 
for P27 and Bz for P28). 
Conclusions 
The work described in this paper complements the results 
described in a previous communication,[4a] expanding the 
application scope of (cyclopentadienone)iron complexes in C=N 
reduction. Owing to the high catalytic activity of our recently 
reported pre-catalyst 1b (Figure 1 B),[4a,b] it has been possible to 
carry out C=N reductions which are usually very sluggish or 
even impossible using the classical ‘Knölker complexes’ 1a and 
2a (Figure 1 A): the application scope of pre-catalyst 1b has 
been expanded to reducing agents different from iPrOH and to 
the CTH of numerous additional aldimines and ketimines, both 
pre-isolated and generated in situ according to a reductive 
amination protocol. Additionally, the kinetics of CTH promoted 
by pre-catalyst 1b have been assessed, showing a pseudo-first 
order profile. 
To further demonstrate the potential of (cyclopentadienone)iron 
complexes in C=N reduction, we have tested chiral pre-catalyst 
1c[4d,e] and its analog 1d (Figure 1 B) in the ATH and AH of 
ketimines and in the reductive amination of ketones. Although 
rather low ee values were obtained, the one described here is 
the first example of imine enantioselective reduction promoted 
by a chiral (cyclopentadienone)iron complex, and provides the 
basis for the future development of more efficient catalysts. 
Experimental Section 
All reactions were carried out in flame-dried glassware with magnetic 
stirring under inert atmosphere (nitrogen or argon), unless otherwise 
stated. Solvents for reactions were distilled over the following drying 
agents and transferred under nitrogen: CH2Cl2 (CaH2), MeOH (CaH2), 
toluene (Na/benzophenone). Dry 2-propanol (over molecular sieves in 
bottles with crown cap) was purchased from Sigma Aldrich and stored 
under nitrogen. The reactions were monitored by analytical thin-layer 
chromatography (TLC) using silica gel 60 F254 pre-coated glass plates 
(0.25 mm thickness). Visualization was accomplished by irradiation with 
a UV lamp and/or staining with a potassium permanganate alkaline 
solution. Flash Column Chromatography was performed using silica gel 
(60 Å, particle size 40-64 μm) as stationary phase, following the 
procedure by Still and co-workers.[15] 1H NMR spectra were recorded on 
a spectrometer operating at 400.13 MHz. Proton chemical shifts are 
reported in ppm (δ) with the solvent reference relative to 
tetramethylsilane (TMS) employed as the internal standard (CDCl3, δ = 
7.26 ppm; CD2Cl2 δ = 5.32 ppm; acetone-d6, δ = 2.05 ppm; toluene-d8, δ 
= 2.08 ppm; CD3OD, δ = 3.31 ppm). The following abbreviations are used 
to describe spin multiplicity: s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet, br = broad signal, dd = doublet-doublet, ddd = doublet-
doublet-doublet, td = triplet-doublet. 13C NMR spectra were recorded 
either on a 400 MHz spectrometer operating at 100 MHz or on a 600 
MHz spectrometer operating at 150 MHz, with complete proton 
decoupling. Carbon chemical shifts are reported in ppm (δ) relative to 
TMS with the respective solvent resonance as the internal standard 
(CDCl3 δ = 77.16 ppm; CD2Cl2 δ = 54.00 ppm; acetone-d6 δ = 29.84 ppm, 
206.26 ppm; CD3OD, δ = 49.00 ppm). The coupling constant values are 
given in Hz. Infrared spectra were recorded on a standard FT/IR 
spectrometer. High resolution mass spectra (HRMS) were performed on 
a Fourier Transform Ion Cyclotron Resonance (FT-ICR) Mass 
Spectrometer APEX II & Xmass software (Bruker Daltonics) – 4.7 T 
Magnet (Magnex) equipped with ESI source, available at the UNITECH-
COSPECT laboratories, at Università degli Studi di Milano. 
 
Materials: commercially available reagents were used as received. 
Ketones and aldehydes used in the substrate screening were purchased 
from commercial suppliers (TCI Chemicals, ACROS, Sigma Aldrich) and 
distilled over PPh3 before use. The other commercially available reagents 
were used as received. 3 Å MS were dried under high vacuum at 200 °C 
and then stored in an oven at 110 °C. 
 
General Procedure for the CTH of pre-formed imines 
Pre-catalyst 1b (3.8 mg, 0.010 mmol, 0.02 equiv.) and Me3NO (1.6 mg, 
0.020 mmol, 0.04 equiv.) were dissolved in dry iPrOH (0.1 mL) and the 
resulting solution, which gradually turned from yellow to dark red, was 
stirred for 20 minutes at r.t.. The imine substrate (0.5 mmol, 1 equiv.) was 
added, followed by dry iPrOH (1.9 mL). The reaction vessel was sealed 
and stirred in a pre-heated oil bath at 100 °C for 18 h. After cooling down, 
the mixture was filtered through a celite pad (rinsing with AcOEt), the 
volatiles were removed and the product was purified by flash column 
chromatography (hexane/AcOEt mixtures with 0.5-1% Et3N). 
 
General Procedure for the reductive amination of aldehydes 
3 Å MS (400 mg), aldehyde (0.5 mmol, 1 equiv.) and amine (0.75 mmol, 
1.5 equiv.) were dissolved in dry toluene (0.5 mL) and the mixture was 
stirred for 1 h at 100 °C. Meanwhile, in another vessel, pre-catalyst 1 (9.6 
mg, 0.025 mmol, 0.05 equiv.) and Me3NO (1.9 mg, 0.025 mmol, 0.05 
equiv.) were dissolved in dry iPrOH (0.25 mL) and stirred for 20 min at r.t.. 
The activated catalyst solution was dispensed into the vessel containing 
the imine, followed by dry iPrOH (1.25 mL). The reaction vessel was 
sealed and stirred in a pre-heated oil bath at 100 °C for 18 h. After 
cooling down, the mixture was filtered through a celite pad (rinsing with 
AcOEt), the volatiles were removed and the crude was purified by flash 
column chromatography (hexane/AcOEt mixtures with 0.5-1% Et3N). 
 
General Procedure for the reductive amination of ketones 
3 Å MS (400 mg), ketone (0.5 mmol, 1 equiv.), amine (0.75 mmol, 1.5 
equiv.) and TFA (4 μL, 0.05 mmol, 0.1 equiv., dispensed as a stock 
solution in toluene) were dissolved in dry toluene (final total volume: 0.5 
    
 
 
 
 
 
mL) and stirred for 2 h at 100 °C. Meanwhile, in another vessel, pre-
catalyst 1 (9.6 mg, 0.025 mmol, 0.05 equiv.) and Me3NO (1.9 mg, 0.025 
mmol, 0.05 equiv.) were dissolved in dry iPrOH (0.25 mL) and stirred for 
20 min at r.t.. Freshly distilled DIPEA (13 μL, 0.075 mmol, 0.15 equiv.) 
and then the activated catalyst solution were dispensed into the vessel 
containing the imine, followed by dry iPrOH (1.25 mL). The reaction 
vessel was sealed and stirred at 100 °C for 18 h. After cooling down, the 
mixture was filtered through a celite pad (rinsing with AcOEt), the 
volatiles were removed and the crude was purified by flash column 
chromatography (hexane/AcOEt mixtures with 0.5-1% Et3N). 
 
Synthesis of complex 1d 
To a stirred solution of 1c (100 mg, 0.19 mmol, 1.0 equiv.) in dry acetone 
(11.5 mL) under argon atmosphere, trimethylamine N-oxide (16 mg, 0.21 
mmol, 1.2 equiv.) and benzonitrile (38 μL, 0.37 mmol, 2.0 equiv.) were 
added. The reaction was refluxed for 20 hours in a sealed tube. After 
cooling down the reaction to r.t., the solvent was removed under reduced 
pressure. Flash chromatography (1:1 hexane/DCM, then 8:2 
hexane/AcOEt) afforded the product 1d as a yellow solid. Yield: 77 mg 
(58%); m.p. = 184-186 °C; [α]D
20 = -13.4 (c = 0.13 in DCM); 1H NMR (400 
MHz, 9:1 CDCl3 / CD3OD): δ 7.75 (t, J = 8.6 Hz, 2H), 7.66 (d, J = 5.8 Hz, 
2H), 7.54 (t, J = 7.6 Hz, 1H), 7.40 (t, J = 7.7 Hz, 2H), 7.32 (dd, J = 12, 7.4 
Hz, 2H), 7.25 (s, 1H), 7.20 (s, 1H), 7.00 (dd, J = 14.7, 7.3 Hz, 2H), 6.82 
(dd, J = 7.6, 6.4 Hz, 2H), 4.25 (d, J = 15.3 Hz, 1H), 3.99 (s, 3H), 3.90 (s, 
3H), 3.31 (s, 2H), 2.84 (dd, J = 31.3, 15.2 Hz, 2H), 0.31 (s, 9H), 0.22 (s, 
9H); 13C NMR (150 MHz, 9:1 CDCl3 / CD3OD): δ 212.58, 211.82, 178.84, 
168.27, 156.30, 155.15, 154.92, 138.15, 137.75, 136.85, 133.80, 133.60, 
133.47, 133.27, 132.61, 129.13, 128.24, 127.95, 127.30, 127.15, 126.76, 
126.62, 126.17, 126.04, 123.87, 123.61, 111.94, 105.76, 105.32, 105.08, 
73.09, 55.25, 55.10, 54.53, 29.82, 25.80, 0.38; FT-IR: ν = 2954.1, 2922.6, 
2898.5, 2851.2, 2299.7, 2058.6, 2003.7, 1947.8, 1677.8, 1618.0, 1593.9, 
1446.4, 1422.2, 1407.8, 1328.7, 1238.1, 1195.7, 1109.8, 1018.2, 852.4, 
841.8, 745.4, 617.1 cm-1; HRMS (ESI+): m/z 778.21433 [M + H]+ (calcd. 
for C44H43FeNO5Si2: 778.21074). 
 
General Procedure for the ATH of ketimines using complexes 1d 
A flame dried Schlenk tube containing a stirring bar was charged with 
imine (0.5 mmol, 1.0 equiv.), Fe(acac)3 (20 mol%), pre-catalyst 1d (5 
mol%) and dry iPrOH (1 mL) under argon atmosphere. The reaction 
mixture was stirred at 110 °C (preheated oil bath) for 48 h. The reaction 
mixture was cooled down to r.t. and then filtered over deactivated neutral 
alumina (3% of H2O) and rinsed with AcOEt. After removing the solvent 
under reduced pressure, the crude was dissolved in DCM (0.5 mL) and 1 
M hydrochloric acid (0.5 mL) was added. The two-phase mixture was 
stirred for 3 h at r.t. before basifying with 1 M aqueous NaOH. The 
aqueous layer was extracted with AcOEt (3 × 5 mL) and the combined 
organic layers dried over Na2SO4 and concentrated under reduced 
pressure. Flash chromatography (hexane/AcOEt mixtures with 0.5-1% 
Et3N) afforded the product amine. Ninhydrin staining visualizes the 
product amine (pale red spot) and p-anisidine (dark red spot). 
 
General Procedure for the AH of ketimines using complex 1d 
A 10 mL flame-dried autoclave vial containing a stirring bar was charged 
with imine (0.5 mmol, 1.0 equiv.), Fe(acac)3 (20 mol%), pre-catalyst 1d (5 
mol%) and dry methanol (1 mL) under argon atmosphere. The autoclave 
was pressurized to 50 bars of hydrogen and stirred at 85 °C for 18 h. The 
reaction mixture was cooled down to r.t. and then filtered over 
deactivated neutral alumina (3% of H2O) and rinsed with AcOEt. After 
removing the solvent under reduced pressure, the crude was dissolved in 
DCM (0.5 mL) and hydrochloric acid (1 M, 0.5 mL) was added. The two-
phase mixture was stirred for 3 h. at r.t. before basifying with 1 M 
aqueous NaOH. The aqueous layer was extracted with AcOEt (3 × 5 mL) 
and the combined organic layers were dried over Na2SO4 and 
concentrated under reduced pressure. Flash chromatography 
(hexane/AcOEt mixtures with 0.5-1% Et3N) afforded the amine product. 
Ninhydrin staining allowed to visualize the product amine (pale red spot) 
and p-anisidine (dark red spot). 
 
General Procedure for the enantioselective reductive amination of 
ketones using complex 1d 
A 10 mL flame-dried autoclave vial containing a stirring bar was charged 
with ketone (0.2 mmol, 1.0 equiv., 0.5 M), phenethylamine (29 mg, 0.24 
mmol, 1.2 equiv.) and dry MeOH (0.27 mL) under argon. The reaction 
mixture was heated to reflux in the sealed autoclave vial for 1 h. A 
solution of complex 1d (7.9 mg, 0.01 mmol, 0.05 equiv.) in dry methanol 
(0.13 mL) was then added to the autoclave vial. The autoclave was 
pressurized to the final pressure of hydrogen (50 bar) and stirred at 85 °C 
for 18 h. After cooling down to r.t. and careful venting of remaining 
hydrogen, the reaction mixture was filtered over deactivated neutral 
alumina (3% of H2O) rinsing with AcOEt. After removing the solvent 
under reduced pressure, the product was purified by flash column 
chromatography (hexane/AcOEt mixtures with 0.5-1% Et3N). 
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